BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260801
DTEND;VALUE=DATE:20260802
DTSTAMP:20251216T233150Z
CREATED:20251216T233138Z
LAST-MODIFIED:20251216T233150Z
UID:10000505-1785542400-1785628799@oncodaily.com
SUMMARY:OPN New Jersey - New York Chapter Conference 2026
DESCRIPTION:The 2026 OPN New Jersey – New York Chapter Conference is a regional oncology pharmacy summit scheduled for August 1\, 2026\, at the New York Marriott Marquis in New York City. \nHosted by the Oncology Pharmacy Network (OPN) and Horizon CME\, this collaborative event brings together hematology/oncology pharmacy clinicians – including pharmacists and pharmacy technicians – to network and discuss emerging agents\, updated clinical guidelines\, and strategies for optimizing patient care. \nRegister.
URL:https://oncodaily.com/event/opn-new-jersey-429684
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-New-Jersey-New-York.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260614T151721Z
CREATED:20260614T151721Z
LAST-MODIFIED:20260614T151721Z
UID:10000761-1786060800-1786233599@oncodaily.com
SUMMARY:2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer)
DESCRIPTION:The 2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer) will bring together many of the world’s leading oncology researchers\, physician-scientists\, and clinical innovators on August 7-8\, 2026\, at the New York Marriott Marquis in Times Square. \nThe multidisciplinary conference is designed to bridge groundbreaking translational research with real-world patient care\, highlighting the latest advances in precision medicine\, targeted therapies\, antibody-drug conjugates (ADCs)\, biomarker-driven treatment strategies\, immunotherapy\, radiopharmaceuticals\, and early-phase clinical trials. The program will feature nationally recognized experts from leading institutions including Memorial Sloan Kettering Cancer Center\, Stanford Cancer Institute\, Mayo Clinic\, Dana-Farber Cancer Institute\, Vanderbilt University Medical Center\, MD Anderson Cancer Center\, and NEXT Oncology. \nAmong the distinguished faculty is Dr. Sarat Chandarlapaty of Memorial Sloan Kettering Cancer Center\, who will deliver the prestigious Daniel D. Von Hoff Keynote Lecture. Dr. Chandarlapaty is internationally recognized for his contributions to breast cancer research and precision oncology. \nThe summit also features an exceptional lineup of speakers who are helping define the future of cancer therapeutics\, including: \n• Dr. Vivek Subbiah\, Stanford Cancer Institute\, a globally recognized leader in drug development and precision oncology\, presenting on the evolution and future of tumor-agnostic therapies. \n• Dr. Eileen M. O’Reilly\, Memorial Sloan Kettering Cancer Center\, one of the nation’s foremost experts in gastrointestinal malignancies\, discussing recent precision medicine advances in GI cancers. \n• Dr. Alexander I. Spira\, Chief Scientific Officer of NEXT Oncology\, presenting emerging developments in RAS-targeted therapies and next-generation oncology drug development. \n• Dr. Anthony W. Tolcher\, Founder and CEO of NEXT Oncology and a pioneer in early-phase clinical trials\, discussing innovative approaches including RAS PROTACs and molecular glues. \n• Dr. Cathy Eng\, Vanderbilt University Medical Center and Co-Chair of the National Cancer Institute Gastrointestinal Steering Committee\, presenting on ctDNA applications and biomarker-driven management strategies in colorectal cancer. \n• Dr. Vamsi Velcheti\, Mayo Clinic\, an internationally recognized thoracic oncologist and cancer researcher\, discussing the development of antibody-drug conjugates in lung cancer. \n• Dr. Guru P. Sonpavde\, AdventHealth Cancer Institute\, a leading investigator in genitourinary oncology and phase I clinical research\, presenting on ADC innovation in GU malignancies. \n• Dr. Eytan Stein\, Memorial Sloan Kettering Cancer Center\, one of the nation’s leading leukemia drug development experts\, discussing precision medicine advances in myeloproliferative neoplasms. \n• Dr. Ghassan K. Abou-Alfa\, Memorial Sloan Kettering Cancer Center\, a globally respected authority in hepatobiliary cancers\, presenting emerging innovations in HER2-targeted therapy. \n• Dr. Ulka Vaishampayan\, University of Michigan Rogel Cancer Center\, discussing advances in alpha-emitter radiopharmaceutical therapies for prostate cancer. \nAdditional presentations will explore emerging TP53-targeted therapies\, PRMT5 inhibitors\, novel biomarker methodologies\, digital biomarkers\, clinical trial innovation\, patient-reported outcomes\, decentralized clinical trials\, and next-generation immunotherapy approaches. \n“The pace of innovation in oncology has never been greater\,” said Dr. Hani Babiker\, Course Director and Associate Professor of Medicine at Mayo Clinic. “STOP Cancer was created to provide a forum where clinicians\, researchers\, and healthcare professionals can engage directly with leaders developing the therapies and technologies that will shape the future of cancer care.” \nThe conference is intended for medical oncologists\, hematologists\, radiation oncologists\, surgical oncologists\, advanced practice providers\, pharmacists\, nurses\, fellows\, researchers\, and other healthcare professionals involved in cancer care. \nRegister now.
URL:https://oncodaily.com/event/precision-medicine-520908
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/Annotation-2026-06-14-191317.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260919
DTEND;VALUE=DATE:20260920
DTSTAMP:20251217T231732Z
CREATED:20251217T231720Z
LAST-MODIFIED:20251217T231732Z
UID:10000506-1789776000-1789862399@oncodaily.com
SUMMARY:OPN California North Chapter Conference 2026
DESCRIPTION:The 2026 OPN California North Chapter Conference is a one-day regional summit tailored for hematology and oncology pharmacy clinicians\, including pharmacists and pharmacy technicians. \nOrganized by the Oncology Pharmacy Network (OPN) in collaboration with Horizon CME\, the conference focuses on the latest evidence-based strategies in cancer care and provides a platform for professional networking and collaboration. The event is part of a series of regional meetings aimed at optimizing patient outcomes through advanced pharmaceutical insights.
URL:https://oncodaily.com/event/opn-california-430229
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-California-1.webp
END:VEVENT
END:VCALENDAR